Patients, AI, and RWE were all hot topics at this year’s ASCO meeting
This year’s ASCO meeting once again had a strong focus on patients, along with exciting new data in oncology research. Several other themes were prominently featured including real world evidence, the use of artificial intelligence tools, and the continuing problem of financial toxicity experienced by cancer patients.
Lumanity had over 20 colleagues at ASCO interacting with patient advocacy groups, meeting with academic, clinical, and pharma leaders, and attending great sessions.
Our ASCO report
We have compiled a comprehensive report detailing our key learnings from this year’s meeting. Our report includes select themes from the conference, such as:
- Patient partnering
- Real world evidence
- Moving novel therapies earlier in treatment paradigms
- Decision support tools and AI
- Health equity
Contact us to discover the insights from our report.
